Eisai Oncology Medical

Many patients with hormone receptor-positive metastatic breast cancer can develop resistance to hormone therapies over time. Learn more about the key subtypes in breast cancer on our disease awareness website.

Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) can be complex. Here, Robert Ferris, MD, discusses the different modalities available, and how he decides to treat his HNSCC patients. #hncsm

NSCLC is the most common form of lung cancer, accounting for 85% of all cases. Given the complexity of the disease, the patient journey may vary from person to person. Here, Dr. Estelamari Rodriguez discusses the typical patient journey prior to being diagnosed.

Through selectively targeting cancer cells, antibody derivatives called antibody-drug conjugates (ADCs) can deliver small-molecule drugs to specific cells including cancer cells. Cancer care is evolving with more research on ADCs. Learn more about what we do at Eisai Oncology: https://lnkd.in/d7tPmCj

Supportive care is integral to the well-being of cancer patients. We are in Lille, France, at the MASCC/AFSOS/ISOO 2024 Annual Meeting to discuss the latest in cancer management. Learn about our work in oncology: https://ow.ly/C82050RZj0u #MASCC24 #oncoloogy

We’re in Munich to attend the European Society for Medical Oncology Gastrointestinal Cancers Congress. Excited to connect with peers and explore the latest developments in gastrointestinal cancer treatment and research. Learn about gastrointestinal cancers: https://ow.ly/9VbT50Sa2Zn #ESMOGI24 #GICancer #hcc

Globally, liver cancer is the third leading cause of cancer death. In some countries, liver cancer is the most common type of cancer, which is why we continue to pursue ways to improve the lives of patients and their families living with hepatocellular carcinoma (HCC). https://lnkd.in/d_G-cbkt

The death rate of Black women who are affected by uterine cancer is about double that of White women, reflecting the largest Black-White disparity in 5-year relative survival of all cancers. Let's raise awareness of health disparities in hope of improving early-stage diagnosis trends, leading to greater possibility of successful treatment. Explore our commitment in gynecological cancers: https://ow.ly/jPkR50RZiHA #GYNCSM

Everyone deserves access to high-quality health care, which is why we're working to develop therapies that can improve health outcomes for those living with cancer. Discover the impact of our human health care (hhc) mission and join us in creating a healthier future. #healthcare

Thrilled to attend the European Society for Medical Oncology Gynaecological Cancers Congress. We are eager to engage with leading experts and discuss the latest advancements in gynecological cancer research. Learn about gynecological cancer: https://ow.ly/cjwL50Sa2OX #ESMOGynae24 #GynOnc #gynecologicalcancer